missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CYP26A1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA599239
This item is not returnable.
View return policy
Description
Antibody detects endogenous levels of total CYP26A1.
CYP26A1 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein acts on retinoids, including all-trans-retinoic acid (RA), with both 4-hydroxylation and 18-hydroxylation activities. This enzyme regulates the cellular level of retinoic acid which is involved in regulation of gene expression in both embryonic and adult tissues.
Specifications
| CYP26A1 | |
| Polyclonal | |
| Unconjugated | |
| CYP26A1 | |
| CP26; Cyp26; CYP26A1; Cytochrome P450 26A1; cytochrome P450 family 26 subfamily A member 1; cytochrome P450 retinoic acid-inactivating 1; cytochrome P450, 26, retinoic acid; cytochrome P450, 26, retinoic acid A1; cytochrome P450, family 26, subfamily A, polypeptide 1; cytochrome P450, subfamily XXVIA, polypeptide 1; cytochrome P450RAI; hP450RAI; P450, retinoic acid-inactivating, 1; P450RA; P450RAI; P450RAI1; RAH; Retinoic acid 4-hydroxylase; retinoic acid hydrolase; retinoic acid hydroxylase; retinoic acid-metabolizing cytochrome | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 13082, 154985, 1592 | |
| -20°C | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O43174, O55127 | |
| CYP26A1 | |
| A synthesized peptide derived from human CYP26A1(Accession O43174), corresponding to amino acid residues G257-S307. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido